IMNM
Price:
$12.66
Market Cap:
$760.29M
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.[Read more]
Industry
Biotechnology
IPO Date
2020-10-02
Stock Exchange
NASDAQ
Ticker
IMNM
According to Immunome, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 597.73M. This represents a change of 252.66% compared to the average of 169.49M of the last 4 quarters.
The mean historical Enterprise Value of Immunome, Inc. over the last ten years is 58.38M. The current 597.73M Enterprise Value has changed 102.29% with respect to the historical average. Over the past ten years (40 quarters), IMNM's Enterprise Value was at its highest in in the June 2024 quarter at 568.67M. The Enterprise Value was at its lowest in in the March 2024 quarter at -40168729.53.
Average
58.38M
Median
66.95M
Minimum
-6341749.44
Maximum
115.30M
Discovering the peaks and valleys of Immunome, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.60%
Maximum Annual Enterprise Value = 115.30M
Minimum Annual Increase = -1686.77%
Minimum Annual Enterprise Value = -6341749.44
Year | Enterprise Value | Change |
---|---|---|
2023 | 115.30M | 1.60% |
2022 | 6.77M | -93.27% |
2021 | 100.63M | -1686.77% |
2020 | -6341749.44 | -108.42% |
2019 | 75.28M | 28.43% |
The current Enterprise Value of Immunome, Inc. (IMNM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
74.23M
5-year avg
58.33M
10-year avg
58.38M
Immunome, Inc.’s Enterprise Value is greater than Anebulo Pharmaceuticals, Inc. (45.92M), greater than Adagene Inc. (59.89M), greater than Acrivon Therapeutics, Inc. Common Stock (200.11M), less than AnaptysBio, Inc. (906.87M), less than Mineralys Therapeutics, Inc. (603.95M), greater than Molecular Partners AG (57.05M), greater than MediciNova, Inc. (38.55M), greater than Champions Oncology, Inc. (61.85M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Aerovate Therapeutics, Inc. (48.31M), greater than Rezolute, Inc. (237.20M), greater than AN2 Therapeutics, Inc. (5.76M), greater than Gain Therapeutics, Inc. (39.43M), greater than TFF Pharmaceuticals, Inc. (2.31M), greater than aTyr Pharma, Inc. (138.44M), greater than IN8bio, Inc. (10.27M), greater than Lantern Pharma Inc. (22.44M), greater than Ikena Oncology, Inc. (47.35M), less than Celcuity Inc. (641.13M),
Company | Enterprise Value | Market cap |
---|---|---|
45.92M | $49.01M | |
59.89M | $135.03M | |
200.11M | $241.89M | |
906.87M | $599.77M | |
603.95M | $671.81M | |
57.05M | $246.63M | |
38.55M | $82.40M | |
61.85M | $57.64M | |
-20511738.00 | $108.71M | |
48.31M | $78.69M | |
237.20M | $305.37M | |
5.76M | $32.53M | |
39.43M | $55.56M | |
2.31M | $6.62M | |
138.44M | $131.12M | |
10.27M | $14.59M | |
22.44M | $35.20M | |
47.35M | $82.52M | |
641.13M | $575.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunome, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Immunome, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Immunome, Inc. (IMNM)?
What is the 3-year average Enterprise Value for Immunome, Inc. (IMNM)?
What is the 5-year average Enterprise Value for Immunome, Inc. (IMNM)?
How does the current Enterprise Value for Immunome, Inc. (IMNM) compare to its historical average?